Diagnostic Accuracy of Cystatin C as a Marker of Kidney Disease in Patients with Multiple Myeloma: Calculated Glomerular Filtration Rate Formulas Are Equally Useful
- 1 October 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (10) , 1848-1851
- https://doi.org/10.1373/clinchem.2004.036947
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Screening for renal disease using serum creatinine: who are we missing?Nephrology Dialysis Transplantation, 2001
- Developments in the assessment of glomerular filtration rateClinica Chimica Acta; International Journal of Clinical Chemistry, 2000
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999
- Presentation and survival of patients with severe renal failure and myelomaQJM: An International Journal of Medicine, 1997
- Acute myeloma kidneyKidney International, 1995
- Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinineKidney International, 1995
- Treatment of Renal Failure Associated With Multiple MyelomaArchives of internal medicine (1960), 1990
- Creatinine Clearance: A Redundant Clinical InvestigationAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1986
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Renal Inulin Clearance versus Total Plasma Clearance of51Cr-EDTAScandinavian Journal of Clinical and Laboratory Investigation, 1969